These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3691608)

  • 21. Change in serum pH in the bioassay of aminoglycoside antibiotics.
    Wolff M; Chmel H; Eng RH
    J Infect Dis; 1982 Apr; 145(4):585. PubMed ID: 7069238
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM; Weverling GJ; van Ketel RJ; Speelman P
    Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
    Matzke GR; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Jan; 25(1):128-30. PubMed ID: 6703676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of serum aminoglycoside levels with once-daily dosing.
    Paterson DL; Robson JM; Wagener MM; Peters M
    Pathology; 1998 Aug; 30(3):289-94. PubMed ID: 9770195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usage of aminoglycosides and control of therapy].
    Bruun JN; Nordahl H; Eng J
    Tidsskr Nor Laegeforen; 1982 Jan; 102(2):93-5. PubMed ID: 7101252
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gas-liquid chromatographic method for the assay of aminoglycoside antibiotics in serum.
    Mayhew JW; Gorbach SL
    J Chromatogr; 1978 Apr; 151(2):133-46. PubMed ID: 641129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Error in recovery rate of aminoglycosides from uraemic sera.
    Stessman J; Michel J; Sacks T
    Chemotherapy; 1977; 23(3):142-8. PubMed ID: 851502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of the EMIT gentamicin and tobramycin procedure to the IL microcentrifugal analyzer.
    Iosefsohn M; Boeckx RL; Hicks JM
    Ther Drug Monit; 1981; 3(4):365-70. PubMed ID: 7039009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis.
    Hiraki Y; Hiraike M; Nagano M; Ozono Y; Manabe K; Misumi N; Tsuji Y; Kamimura H; Karube Y
    Scand J Infect Dis; 2012 Aug; 44(8):630-4. PubMed ID: 22339591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
    Weibert R; Keane W; Shapiro F
    Trans Am Soc Artif Intern Organs; 1976; 22():439-43. PubMed ID: 951863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
    Phillips LE; Martin RF; Luper WE; Rogers TE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):567-70. PubMed ID: 7247379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin in renal impairment.
    Bechtol LD; Black HR
    Am J Med Sci; 1975; 269(3):317-21. PubMed ID: 1155490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.